vs
Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and CABOT CORP (CBT). Click either name above to swap in a different company.
CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $16.7M, roughly 51.0× ASP Isotopes Inc.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $-47.4M). Over the past eight quarters, ASP Isotopes Inc.'s revenue compounded faster (345.2% CAGR vs -8.7%).
ASP Isotopes Inc.ASPIEarnings & Financial Report
ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.
Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.
ASPI vs CBT — Head-to-Head
Income Statement — Q4 2025 vs Q1 2026
| Metric | | |
|---|---|---|
| Revenue | $16.7M | $849.0M |
| Net Profit | — | $73.0M |
| Gross Margin | 12.5% | 24.9% |
| Operating Margin | — | 15.2% |
| Net Margin | — | 8.6% |
| Revenue YoY | 1295.7% | -11.1% |
| Net Profit YoY | -586.8% | -21.5% |
| EPS (diluted) | — | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.7M | $849.0M | ||
| Q3 25 | $4.9M | $899.0M | ||
| Q2 25 | $1.2M | $923.0M | ||
| Q1 25 | $1.1M | $936.0M | ||
| Q4 24 | $1.2M | $955.0M | ||
| Q3 24 | $1.1M | $1.0B | ||
| Q2 24 | $1.0M | $1.0B | ||
| Q1 24 | $840.4K | $1.0B |
| Q4 25 | — | $73.0M | ||
| Q3 25 | $-12.9M | $43.0M | ||
| Q2 25 | $-75.2M | $101.0M | ||
| Q1 25 | $-8.5M | $94.0M | ||
| Q4 24 | — | $93.0M | ||
| Q3 24 | $-7.4M | $137.0M | ||
| Q2 24 | $-8.9M | $109.0M | ||
| Q1 24 | $-7.0M | $84.0M |
| Q4 25 | 12.5% | 24.9% | ||
| Q3 25 | 8.7% | 24.5% | ||
| Q2 25 | 47.7% | 26.4% | ||
| Q1 25 | 29.7% | 25.7% | ||
| Q4 24 | 50.7% | 24.6% | ||
| Q3 24 | 27.0% | 24.0% | ||
| Q2 24 | 41.2% | 25.2% | ||
| Q1 24 | 33.2% | 24.1% |
| Q4 25 | — | 15.2% | ||
| Q3 25 | -306.1% | 15.2% | ||
| Q2 25 | -998.8% | 18.1% | ||
| Q1 25 | -721.9% | 17.3% | ||
| Q4 24 | — | 16.2% | ||
| Q3 24 | -499.6% | 15.0% | ||
| Q2 24 | -729.5% | 16.9% | ||
| Q1 24 | -691.9% | 15.3% |
| Q4 25 | — | 8.6% | ||
| Q3 25 | -263.7% | 4.8% | ||
| Q2 25 | -6271.7% | 10.9% | ||
| Q1 25 | -768.1% | 10.0% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | -676.2% | 13.7% | ||
| Q2 24 | -868.8% | 10.7% | ||
| Q1 24 | -828.8% | 8.2% |
| Q4 25 | — | $1.37 | ||
| Q3 25 | $-0.15 | $0.80 | ||
| Q2 25 | $-1.03 | $1.86 | ||
| Q1 25 | $-0.12 | $1.69 | ||
| Q4 24 | — | $1.67 | ||
| Q3 24 | $-0.12 | $2.41 | ||
| Q2 24 | $-0.24 | $1.94 | ||
| Q1 24 | $-0.16 | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $333.3M | $230.0M |
| Total DebtLower is stronger | $14.4M | — |
| Stockholders' EquityBook value | $204.2M | $1.6B |
| Total Assets | $498.0M | $3.8B |
| Debt / EquityLower = less leverage | 0.07× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $333.3M | $230.0M | ||
| Q3 25 | $113.9M | $258.0M | ||
| Q2 25 | $67.7M | $239.0M | ||
| Q1 25 | $56.0M | $213.0M | ||
| Q4 24 | $61.9M | $183.0M | ||
| Q3 24 | $51.6M | $223.0M | ||
| Q2 24 | — | $197.0M | ||
| Q1 24 | — | $206.0M |
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | $1.1B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $204.2M | $1.6B | ||
| Q3 25 | $74.1M | $1.6B | ||
| Q2 25 | $25.2M | $1.5B | ||
| Q1 25 | $42.5M | $1.4B | ||
| Q4 24 | $47.9M | $1.4B | ||
| Q3 24 | $38.7M | $1.4B | ||
| Q2 24 | $11.0M | $1.3B | ||
| Q1 24 | $10.5M | $1.4B |
| Q4 25 | $498.0M | $3.8B | ||
| Q3 25 | $225.9M | $3.8B | ||
| Q2 25 | $135.9M | $3.8B | ||
| Q1 25 | $90.9M | $3.8B | ||
| Q4 24 | $94.3M | $3.6B | ||
| Q3 24 | $84.1M | $3.7B | ||
| Q2 24 | $54.8M | $3.6B | ||
| Q1 24 | $45.4M | $3.6B |
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | 0.70× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | 0.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-37.8M | $126.0M |
| Free Cash FlowOCF − Capex | $-47.4M | $57.0M |
| FCF MarginFCF / Revenue | -284.7% | 6.7% |
| Capex IntensityCapex / Revenue | 57.9% | 8.1% |
| Cash ConversionOCF / Net Profit | — | 1.73× |
| TTM Free Cash FlowTrailing 4 quarters | $-74.6M | $401.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-37.8M | $126.0M | ||
| Q3 25 | $-8.9M | $219.0M | ||
| Q2 25 | $-7.9M | $249.0M | ||
| Q1 25 | $-3.2M | $73.0M | ||
| Q4 24 | $-16.7M | $124.0M | ||
| Q3 24 | $-4.8M | $204.0M | ||
| Q2 24 | $-5.1M | $207.0M | ||
| Q1 24 | $-3.0M | $176.0M |
| Q4 25 | $-47.4M | $57.0M | ||
| Q3 25 | $-12.0M | $155.0M | ||
| Q2 25 | $-9.7M | $188.0M | ||
| Q1 25 | $-5.5M | $1.0M | ||
| Q4 24 | $-26.4M | $47.0M | ||
| Q3 24 | $-9.3M | $112.0M | ||
| Q2 24 | $-7.7M | $155.0M | ||
| Q1 24 | $-4.2M | $133.0M |
| Q4 25 | -284.7% | 6.7% | ||
| Q3 25 | -245.5% | 17.2% | ||
| Q2 25 | -809.4% | 20.4% | ||
| Q1 25 | -497.4% | 0.1% | ||
| Q4 24 | -2209.3% | 4.9% | ||
| Q3 24 | -857.3% | 11.2% | ||
| Q2 24 | -757.8% | 15.3% | ||
| Q1 24 | -501.7% | 13.1% |
| Q4 25 | 57.9% | 8.1% | ||
| Q3 25 | 64.4% | 7.1% | ||
| Q2 25 | 150.1% | 6.6% | ||
| Q1 25 | 209.6% | 7.7% | ||
| Q4 24 | 810.5% | 8.1% | ||
| Q3 24 | 412.3% | 9.2% | ||
| Q2 24 | 256.5% | 5.1% | ||
| Q1 24 | 148.3% | 4.2% |
| Q4 25 | — | 1.73× | ||
| Q3 25 | — | 5.09× | ||
| Q2 25 | — | 2.47× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | 1.49× | ||
| Q2 24 | — | 1.90× | ||
| Q1 24 | — | 2.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASPI
Segment breakdown not available.
CBT
| Reinforcement Materials | $520.0M | 61% |
| Performance Chemicals | $300.0M | 35% |
| Shipping And Handling | $25.0M | 3% |
| Other Products And Services | $4.0M | 0% |
